Lack of adverse reactions in ivermectin treatment of onchocerciasis

Twenty-two years of blackfly control in the onchocerciasis control programme in West Africa.

Parasitology today (Personal ed.)·2004

Pseudouridines and pseudouridine synthases of the ribosome.

Cold Spring Harbor symposia on quantitative biology·2003

The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries.

Annals of tropical medicine and parasitology·2003

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.

Annals of tropical medicine and parasitology·2002

Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).

Annals of tropical medicine and parasitology·2002

Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).

Annals of tropical medicine and parasitology·2002

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Minimal Matricectomy Combined with Lateral Longitudinal Excision Versus Total Nail Avulsion for Ingrown Toenail: A Two-Center Retrospective Cohort Study with Propensity Score Analysis.

Medicina (Kaunas, Lithuania)·2026

Current Advances in Mosquito Bioecology and Control Strategies.

Insects·2026

Integrated Phenotypic and Transcriptomic Analysis of the Effects of a Novel Arylaminoalcohol on Plasmodium falciparum.

Biology·2026

CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing.

Diagnostics (Basel, Switzerland)·2026

The Fate of the Urine Malaria Test in Malaria Diagnosis: Evaluating its Diagnostic Accuracy in Plasmodium Falciparum Detection in Febrile Children in a Low-resource Country.

Nigerian journal of clinical practice·2026

Acute Pancreatitis as a Rare Complication of Plasmodium falciparum Malaria: A Case Report.

Cureus·2026

Related Experiment Videos

Lack of adverse reactions in ivermectin treatment of onchocerciasis

Related Concept Videos

Twenty-two years of blackfly control in the onchocerciasis control programme in West Africa.

Pseudouridines and pseudouridine synthases of the ribosome.

The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries.

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.

Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).

Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Minimal Matricectomy Combined with Lateral Longitudinal Excision Versus Total Nail Avulsion for Ingrown Toenail: A Two-Center Retrospective Cohort Study with Propensity Score Analysis.

Current Advances in Mosquito Bioecology and Control Strategies.

Integrated Phenotypic and Transcriptomic Analysis of the Effects of a Novel Arylaminoalcohol on Plasmodium falciparum.

CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing.

The Fate of the Urine Malaria Test in Malaria Diagnosis: Evaluating its Diagnostic Accuracy in Plasmodium Falciparum Detection in Febrile Children in a Low-resource Country.

Acute Pancreatitis as a Rare Complication of Plasmodium falciparum Malaria: A Case Report.

Related Experiment Videos

Lack of adverse reactions in ivermectin treatment of onchocerciasis

Related Concept Videos

Related Articles